phenyl 3,4-O-isopropylidene-2-O-methylxanthogenato-1-thio-β-L-fucopyranoside

Base Information

Chemical Name:phenyl 3,4-O-isopropylidene-2-O-methylxanthogenato-1-thio-β-L-fucopyranoside
CAS No.:1013427-84-3
Molecular Formula:C₁₇H₂₂O₄S₃
Molecular Weight:386.557
Hs Code.:

Synonyms:phenyl 3,4-O-isopropylidene-2-O-methylxanthogenato-1-thio-β-L-fucopyranoside

Suppliers and Price of phenyl 3,4-O-isopropylidene-2-O-methylxanthogenato-1-thio-β-L-fucopyranoside

Supply Marketing:

Business phase:: The product has achieved commercial mass production^*data from LookChem market partment

Manufacturers and distributors:

Manufacture/Brand
Chemicals and raw materials
Packaging
price

Total 0 raw suppliers

Chemical Property of phenyl 3,4-O-isopropylidene-2-O-methylxanthogenato-1-thio-β-L-fucopyranoside

Chemical Property:

Purity/Quality:

Safty Information:

Pictogram(s):
Hazard Codes:

MSDS Files:

Useful:

Technology Process of phenyl 3,4-O-isopropylidene-2-O-methylxanthogenato-1-thio-β-L-fucopyranoside

There total 1 articles about phenyl 3,4-O-isopropylidene-2-O-methylxanthogenato-1-thio-β-L-fucopyranoside which guide to synthetic route it. The literature collected by LookChem mainly comes from the sharing of users and the free literature resources found by Internet computing technology. We keep the original model of the professional version of literature to make it easier and faster for users to retrieve and use. At the same time, we analyze and calculate the most feasible synthesis route with the highest yield for your reference as below:

synthetic route:

Reference yield: 100.0%

: 75-15-0,12122-00-8
carbon disulfide

: 196397-59-8
phenyl 3,4-O-isopropylidene-1-thio-β-L-fucopyranoside

: 74-88-4
methyl iodide

: 1013427-84-3
phenyl 3,4-O-isopropylidene-2-O-methylxanthogenato-1-thio-β-L-fucopyranoside

Guidance literature:: carbon disulfide; phenyl 3,4-O-isopropylidene-1-thio-β-L-fucopyranoside; With 1H-imidazole; sodium hydride; In tetrahydrofuran; for 0.25h;

methyl iodide; With 1H-imidazole; In tetrahydrofuran; for 1h; Further stages.;
DOI:10.1016/j.tetlet.2007.12.043